| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | SLC25A4 SLC25A5 SLC25A6 SLC25A26 SLC25A32 SLC22A2 LRRC8A SLC35E3 | 3.27e-08 | 59 | 168 | 8 | GO:0015932 |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 6.22e-07 | 59 | 168 | 7 | GO:1901505 | |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 5.78e-06 | 5 | 168 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A4 SLC25A5 SLC25A6 SLC26A5 GRIN1 SLC25A26 SLC26A1 SLC25A32 SLC25A39 SLCO1A2 SLC22A2 LRRC8A | 7.34e-06 | 293 | 168 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 7.79e-06 | 33 | 168 | 5 | GO:0015215 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.81e-05 | 39 | 168 | 5 | GO:0015605 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 3.78e-05 | 23 | 168 | 4 | GO:0005346 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 6.25e-05 | 26 | 168 | 4 | GO:0000295 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 9.19e-05 | 11 | 168 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 9.74e-05 | 29 | 168 | 4 | GO:0015216 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 1.22e-04 | 12 | 168 | 3 | GO:0050815 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.61e-04 | 61 | 168 | 5 | GO:1901682 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.69e-04 | 138 | 168 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 1.99e-04 | 14 | 168 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | transporter activity | ATP8B3 TPTE TRPM4 CACNA2D1 SLC25A4 SLC25A5 SLC25A6 CACNA2D2 ABCA12 PIEZO1 SLC26A5 BAK1 GRIN1 SLC25A26 PKDREJ SLC26A1 SLC25A32 PIEZO2 SLC25A39 SLCO1A2 SLC22A2 LRRC8A SLC35E3 TMEM41B | 2.05e-04 | 1289 | 168 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 3.02e-04 | 16 | 168 | 3 | GO:0043138 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TPTE TRPM4 CACNA2D1 SLC25A4 SLC25A5 SLC25A6 CACNA2D2 ABCA12 PIEZO1 SLC26A5 BAK1 GRIN1 SLC25A26 PKDREJ SLC26A1 SLC25A32 PIEZO2 SLC25A39 SLCO1A2 SLC22A2 LRRC8A SLC35E3 | 3.79e-04 | 1180 | 168 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | calmodulin-dependent protein phosphatase activity | 6.92e-04 | 5 | 168 | 2 | GO:0033192 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 6.92e-04 | 5 | 168 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 6.92e-04 | 5 | 168 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 1.12e-03 | 189 | 168 | 7 | GO:0004721 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 1.63e-03 | 386 | 168 | 10 | GO:0042578 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.84e-03 | 62 | 168 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.88e-03 | 207 | 168 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase activity | 1.91e-03 | 8 | 168 | 2 | GO:0004723 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.93e-03 | 208 | 168 | 7 | GO:0005342 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 2.64e-08 | 40 | 164 | 7 | GO:0072530 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 1.44e-07 | 31 | 164 | 6 | GO:1901679 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 2.63e-07 | 8 | 164 | 4 | GO:1990544 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 9.86e-07 | 96 | 164 | 8 | GO:1901264 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 2.74e-06 | 50 | 164 | 6 | GO:0006862 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 4.88e-06 | 5 | 164 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 4.91e-06 | 15 | 164 | 4 | GO:1901029 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | ADCY10 ATP8B3 SLC25A4 SLC25A5 SLC25A6 ABCA12 SLC25A32 LRRC8A TMEM41B | 6.10e-06 | 162 | 164 | 9 | GO:0015748 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TPTE TRPM4 CACNA2D1 DPP10 SLC25A4 SLC25A5 CACNA2D2 PIEZO1 SLC26A5 BAK1 GRIN1 SLC25A26 PKDREJ YWHAH SLC26A1 STAC2 PIEZO2 ADRB2 PPP3CA PPP3CC PIK3C2A HECW2 SLCO1A2 SLC22A2 LRRC8A SARAF YWHAQ | 1.13e-05 | 1374 | 164 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | sulfur compound transport | 1.29e-05 | 65 | 164 | 6 | GO:0072348 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 1.57e-05 | 40 | 164 | 5 | GO:0015868 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 2.00e-05 | 42 | 164 | 5 | GO:0051503 | |
| GeneOntologyBiologicalProcess | mitochondrial transmembrane transport | 2.23e-05 | 106 | 164 | 7 | GO:1990542 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 2.53e-05 | 44 | 164 | 5 | GO:0015865 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TPTE TRPM4 CACNA2D1 DPP10 SLC25A4 SLC25A5 CACNA2D2 PIEZO1 SLC26A5 BAK1 GRIN1 PKDREJ YWHAH SLC26A1 STAC2 PIEZO2 ADRB2 PPP3CA PPP3CC PIK3C2A HECW2 LRRC8A YWHAQ | 2.58e-05 | 1115 | 164 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 2.67e-05 | 109 | 164 | 7 | GO:1904427 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 3.03e-05 | 23 | 164 | 4 | GO:0035795 | |
| GeneOntologyBiologicalProcess | ATP transport | 3.03e-05 | 23 | 164 | 4 | GO:0015867 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | CACNA2D1 DPP10 SLC26A5 BAK1 GRIN1 YWHAH STAC2 ADRB2 PPP3CA PPP3CC PIK3C2A HECW2 YWHAQ | 3.03e-05 | 417 | 164 | 13 | GO:0034765 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | ADCY10 SLC25A4 SLC25A5 SLC25A6 SLC25A26 NUP205 SLC25A32 LRPPRC LRRC8A SLC35E3 | 3.17e-05 | 249 | 164 | 10 | GO:0015931 |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3.62e-05 | 24 | 164 | 4 | GO:1901028 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane permeability | 5.02e-05 | 26 | 164 | 4 | GO:1905709 | |
| GeneOntologyBiologicalProcess | ADP transport | 1.03e-04 | 12 | 164 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization | 1.32e-04 | 33 | 164 | 4 | GO:0097345 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion import across plasma membrane | 1.33e-04 | 13 | 164 | 3 | GO:1905665 | |
| GeneOntologyBiologicalProcess | membrane depolarization during bundle of His cell action potential | 1.88e-04 | 3 | 164 | 2 | GO:0086048 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | CACNA2D1 DPP10 SLC26A5 BAK1 GRIN1 YWHAH STAC2 ADRB2 PPP3CA PPP3CC PIK3C2A HECW2 SARAF YWHAQ | 2.17e-04 | 577 | 164 | 14 | GO:0043269 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 2.36e-04 | 154 | 164 | 7 | GO:0051928 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | CACNA2D1 DPP10 BAK1 GRIN1 YWHAH STAC2 ADRB2 PPP3CA PPP3CC PIK3C2A HECW2 | 2.39e-04 | 380 | 164 | 11 | GO:1904062 |
| GeneOntologyBiologicalProcess | mitochondrial transport | ADCY10 SLC25A4 SLC25A5 SLC25A6 BAK1 SLC25A26 SLC25A32 SLC25A39 | 2.41e-04 | 205 | 164 | 8 | GO:0006839 |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | CACNA2D1 DPP10 SLC26A5 BAK1 GRIN1 YWHAH MET STAC2 ADRB2 PPP3CA PPP3CC PIK3C2A HECW2 YWHAQ | 2.68e-04 | 589 | 164 | 14 | GO:0034762 |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability involved in apoptotic process | 2.82e-04 | 40 | 164 | 4 | GO:1902110 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization involved in programmed cell death | 3.41e-04 | 42 | 164 | 4 | GO:1902686 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion import across plasma membrane | 4.36e-04 | 19 | 164 | 3 | GO:1905664 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability | 4.45e-04 | 45 | 164 | 4 | GO:0035794 | |
| GeneOntologyBiologicalProcess | negative regulation of G protein-coupled receptor signaling pathway | 4.71e-04 | 81 | 164 | 5 | GO:0045744 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transmembrane transport | 4.75e-04 | 124 | 164 | 6 | GO:0034766 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | TRPM4 CACNA2D1 DPP10 SLC25A4 SLC25A5 CACNA2D2 SLC26A5 BAK1 GRIN1 PKDREJ YWHAH SLC26A1 STAC2 ADRB2 PPP3CA PPP3CC PIK3C2A HECW2 LRRC8A | 4.77e-04 | 1017 | 164 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 4.94e-04 | 174 | 164 | 7 | GO:1904064 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | TRPM4 CACNA2D1 DPP10 SLC25A4 SLC25A5 CACNA2D2 PIEZO1 BAK1 GRIN1 PKDREJ YWHAH STAC2 PIEZO2 ADRB2 PPP3CA PPP3CC PIK3C2A HECW2 | 5.20e-04 | 942 | 164 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of membrane permeability | 5.27e-04 | 83 | 164 | 5 | GO:0090559 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | ADCY10 TRPM4 CACNA2D1 PIEZO1 PPP1R9A SLC26A5 BAK1 GRIN1 YWHAH MET PIEZO2 ADRB2 PPP3CA | 5.45e-04 | 559 | 164 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 5.71e-04 | 48 | 164 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 5.71e-04 | 48 | 164 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | CACNA2D1 DPP10 BAK1 GRIN1 YWHAH STAC2 ADRB2 PPP3CA PPP3CC PIK3C2A HECW2 SARAF | 5.99e-04 | 493 | 164 | 12 | GO:0010959 |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability involved in apoptotic process | 6.18e-04 | 49 | 164 | 4 | GO:1902108 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane permeability | 6.67e-04 | 50 | 164 | 4 | GO:1905710 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | ATR SLC25A4 SLC25A5 PPM1E BAK1 SEMA5A MET TTBK2 ADRB2 KIRREL1 CEP295 YWHAQ DDHD2 | 6.97e-04 | 574 | 164 | 13 | GO:0010638 |
| Domain | 14_3_3 | 1.74e-07 | 7 | 159 | 4 | SM00101 | |
| Domain | 1433_1 | 1.74e-07 | 7 | 159 | 4 | PS00796 | |
| Domain | 1433_2 | 1.74e-07 | 7 | 159 | 4 | PS00797 | |
| Domain | 14-3-3_domain | 1.74e-07 | 7 | 159 | 4 | IPR023410 | |
| Domain | 14-3-3_CS | 1.74e-07 | 7 | 159 | 4 | IPR023409 | |
| Domain | 14-3-3 | 1.74e-07 | 7 | 159 | 4 | PF00244 | |
| Domain | 14-3-3 | 3.45e-07 | 8 | 159 | 4 | IPR000308 | |
| Domain | Mit_uncoupling | 2.37e-06 | 12 | 159 | 4 | IPR002030 | |
| Domain | - | 5.71e-06 | 53 | 159 | 6 | 1.50.40.10 | |
| Domain | Mito_carr | 5.71e-06 | 53 | 159 | 6 | PF00153 | |
| Domain | SOLCAR | 5.71e-06 | 53 | 159 | 6 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 5.71e-06 | 53 | 159 | 6 | IPR018108 | |
| Domain | Mt_carrier_dom | 5.71e-06 | 53 | 159 | 6 | IPR023395 | |
| Domain | PIEZO | 7.20e-05 | 2 | 159 | 2 | PF15917 | |
| Domain | Piezo | 7.20e-05 | 2 | 159 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 7.20e-05 | 2 | 159 | 2 | PF12166 | |
| Domain | Piezo_RRas-bd_dom | 7.20e-05 | 2 | 159 | 2 | IPR031334 | |
| Domain | Piezo_dom | 7.20e-05 | 2 | 159 | 2 | IPR031805 | |
| Domain | C2_dom | 8.21e-05 | 164 | 159 | 8 | IPR000008 | |
| Domain | Aden_trnslctor | 8.83e-05 | 28 | 159 | 4 | IPR002113 | |
| Domain | Ephrin_rec_like | 9.50e-05 | 11 | 159 | 3 | PF07699 | |
| Domain | EGF_dom | 1.26e-04 | 12 | 159 | 3 | IPR024731 | |
| Domain | EGF_3 | 1.26e-04 | 12 | 159 | 3 | PF12947 | |
| Domain | Mit_carrier | 1.51e-04 | 32 | 159 | 4 | IPR002067 | |
| Domain | ARM-type_fold | PDS5B ATR INTS1 MROH5 LYST AP1B1 PIK3C2A NOM1 ASPM PDS5A USP35 | 1.59e-04 | 339 | 159 | 11 | IPR016024 |
| Domain | - | 2.78e-04 | 148 | 159 | 7 | 2.60.40.150 | |
| Domain | VDCC_a2/dsu | 4.27e-04 | 4 | 159 | 2 | IPR013680 | |
| Domain | Sec63 | 4.27e-04 | 4 | 159 | 2 | PF02889 | |
| Domain | Sec63 | 4.27e-04 | 4 | 159 | 2 | SM00973 | |
| Domain | Sec63-dom | 4.27e-04 | 4 | 159 | 2 | IPR004179 | |
| Domain | VGCC_alpha2 | 4.27e-04 | 4 | 159 | 2 | PF08473 | |
| Domain | VWA_N | 7.08e-04 | 5 | 159 | 2 | IPR013608 | |
| Domain | VWA_N | 7.08e-04 | 5 | 159 | 2 | PF08399 | |
| Domain | CUB | 7.95e-04 | 49 | 159 | 4 | PF00431 | |
| Domain | CUB | 8.59e-04 | 50 | 159 | 4 | SM00042 | |
| Domain | C2 | 9.02e-04 | 131 | 159 | 6 | PF00168 | |
| Domain | - | 9.96e-04 | 52 | 159 | 4 | 2.60.120.290 | |
| Domain | PH_12 | 1.06e-03 | 6 | 159 | 2 | PF16457 | |
| Domain | CUB | 1.07e-03 | 53 | 159 | 4 | PS01180 | |
| Domain | WHTH_DNA-bd_dom | 1.12e-03 | 242 | 159 | 8 | IPR011991 | |
| Domain | C2 | 1.14e-03 | 137 | 159 | 6 | SM00239 | |
| Domain | Ephrin_rec_like | 1.21e-03 | 25 | 159 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.21e-03 | 25 | 159 | 3 | IPR011641 | |
| Domain | cEGF | 1.36e-03 | 26 | 159 | 3 | PF12662 | |
| Domain | cEGF | 1.36e-03 | 26 | 159 | 3 | IPR026823 | |
| Domain | C2 | 1.37e-03 | 142 | 159 | 6 | PS50004 | |
| Domain | CUB_dom | 1.41e-03 | 57 | 159 | 4 | IPR000859 | |
| Domain | S04_transporter_CS | 1.47e-03 | 7 | 159 | 2 | IPR018045 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 2.62e-08 | 12 | 116 | 5 | MM14482 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 9.73e-08 | 15 | 116 | 5 | M26902 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 2.72e-07 | 18 | 116 | 5 | MM14510 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 8.33e-07 | 40 | 116 | 6 | MM14473 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 2.05e-06 | 12 | 116 | 4 | M45022 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 2.05e-06 | 12 | 116 | 4 | MM15443 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 2.94e-06 | 13 | 116 | 4 | M47589 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 2.94e-06 | 13 | 116 | 4 | M27708 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 4.18e-06 | 30 | 116 | 5 | M17814 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 5.54e-06 | 15 | 116 | 4 | M47691 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 5.69e-06 | 55 | 116 | 6 | M7455 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 7.34e-06 | 16 | 116 | 4 | M46428 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.22e-05 | 18 | 116 | 4 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 1.53e-05 | 19 | 116 | 4 | M47677 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 1.81e-05 | 67 | 116 | 6 | M295 | |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 2.34e-05 | 21 | 116 | 4 | M48088 | |
| Pathway | PID_P38_MK2_PATHWAY | 2.34e-05 | 21 | 116 | 4 | M199 | |
| Pathway | REACTOME_APOPTOSIS | 2.99e-05 | 108 | 116 | 7 | MM14471 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 3.42e-05 | 23 | 116 | 4 | MM15216 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.62e-05 | 46 | 116 | 5 | M239 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 5.66e-05 | 26 | 116 | 4 | M247 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 6.25e-05 | 10 | 116 | 3 | M47694 | |
| Pathway | PID_NFAT_3PATHWAY | 7.24e-05 | 53 | 116 | 5 | M113 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.10e-04 | 178 | 116 | 8 | M2890 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 1.13e-04 | 12 | 116 | 3 | M27728 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.13e-04 | 12 | 116 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 1.13e-04 | 12 | 116 | 3 | M27939 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.46e-04 | 13 | 116 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.46e-04 | 13 | 116 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.46e-04 | 13 | 116 | 3 | M47703 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.70e-04 | 142 | 116 | 7 | MM15178 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 1.85e-04 | 14 | 116 | 3 | MM1473 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 1.85e-04 | 14 | 116 | 3 | M47692 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.87e-04 | 35 | 116 | 4 | M249 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.07e-04 | 66 | 116 | 5 | MM15925 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 2.09e-04 | 36 | 116 | 4 | M271 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 2.30e-04 | 15 | 116 | 3 | M15181 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 2.33e-04 | 37 | 116 | 4 | M1029 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.81e-04 | 16 | 116 | 3 | M47695 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 3.37e-04 | 113 | 116 | 6 | M16817 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 3.39e-04 | 159 | 116 | 7 | M39373 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.05e-04 | 18 | 116 | 3 | M47659 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 4.19e-04 | 43 | 116 | 4 | M881 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.78e-04 | 19 | 116 | 3 | M47760 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 5.59e-04 | 20 | 116 | 3 | MM1445 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 5.59e-04 | 20 | 116 | 3 | M47688 | |
| Pathway | PID_LKB1_PATHWAY | 5.91e-04 | 47 | 116 | 4 | M87 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 6.48e-04 | 21 | 116 | 3 | M11650 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 6.48e-04 | 21 | 116 | 3 | M47689 | |
| Pathway | REACTOME_APOPTOSIS | 6.90e-04 | 179 | 116 | 7 | M15303 | |
| Pathway | PID_FOXO_PATHWAY | 6.93e-04 | 49 | 116 | 4 | M136 | |
| Pathway | BIOCARTA_G2_PATHWAY | 7.46e-04 | 22 | 116 | 3 | MM1365 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.46e-04 | 22 | 116 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.46e-04 | 22 | 116 | 3 | M47675 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 7.46e-04 | 22 | 116 | 3 | MM15656 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 8.07e-04 | 51 | 116 | 4 | M7955 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 8.53e-04 | 23 | 116 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.53e-04 | 23 | 116 | 3 | M47676 | |
| Pathway | BIOCARTA_G2_PATHWAY | 9.69e-04 | 24 | 116 | 3 | M8560 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 1.06e-03 | 94 | 116 | 5 | M1080 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.09e-03 | 25 | 116 | 3 | M1547 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.23e-03 | 26 | 116 | 3 | MM1371 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION | 1.37e-03 | 7 | 116 | 2 | M47869 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.79e-03 | 211 | 116 | 7 | M27436 | |
| Pathway | BIOCARTA_PLK3_PATHWAY | 1.82e-03 | 8 | 116 | 2 | M22021 | |
| Pubmed | 3.38e-09 | 13 | 171 | 5 | 34654719 | ||
| Pubmed | 4.46e-09 | 28 | 171 | 6 | 20012529 | ||
| Pubmed | Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. | 8.40e-09 | 6 | 171 | 4 | 10713667 | |
| Pubmed | The interaction between casein kinase Ialpha and 14-3-3 is phosphorylation dependent. | 8.40e-09 | 6 | 171 | 4 | 19860830 | |
| Pubmed | 1.95e-08 | 7 | 171 | 4 | 10441394 | ||
| Pubmed | Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. | 1.95e-08 | 7 | 171 | 4 | 15023544 | |
| Pubmed | 1.95e-08 | 7 | 171 | 4 | 10620507 | ||
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 1.95e-08 | 7 | 171 | 4 | 36096339 | |
| Pubmed | 1.95e-08 | 7 | 171 | 4 | 27030597 | ||
| Pubmed | The expression of seven 14-3-3 isoforms in human meningioma. | 1.95e-08 | 7 | 171 | 4 | 20388496 | |
| Pubmed | 1.95e-08 | 7 | 171 | 4 | 22588126 | ||
| Pubmed | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. | 1.95e-08 | 7 | 171 | 4 | 12383250 | |
| Pubmed | 1.95e-08 | 7 | 171 | 4 | 16868027 | ||
| Pubmed | 1.95e-08 | 7 | 171 | 4 | 31906564 | ||
| Pubmed | 1.95e-08 | 7 | 171 | 4 | 21390248 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | SLC25A5 SLC25A6 INTS1 DYRK1A YWHAB YWHAH YWHAZ HNRNPF NUP205 ZBTB44 MTA1 PPP3CC ZFHX4 NOM1 PDS5A YWHAQ | 3.59e-08 | 583 | 171 | 16 | 29844126 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B CACNA2D1 NIBAN1 EMC3 SLC25A5 SLC25A6 PPP1R9A INTS1 DARS1 YWHAB YWHAH YWHAZ HNRNPF SCAF4 NUP205 LRPPRC PBRM1 UBA6 RP2 YWHAQ ASCC3 | 3.77e-08 | 1024 | 171 | 21 | 24711643 |
| Pubmed | 3.89e-08 | 8 | 171 | 4 | 15708996 | ||
| Pubmed | Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. | 3.89e-08 | 8 | 171 | 4 | 9524113 | |
| Pubmed | 3.89e-08 | 8 | 171 | 4 | 16045749 | ||
| Pubmed | 3.89e-08 | 8 | 171 | 4 | 18332103 | ||
| Pubmed | 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. | 3.89e-08 | 8 | 171 | 4 | 23622247 | |
| Pubmed | 4.63e-08 | 103 | 171 | 8 | 21706016 | ||
| Pubmed | PPP1R9A GRIN1 GRM3 YWHAB YWHAH YWHAZ PTK2 LRPPRC PPP3CA PLCL1 YWHAQ | 5.31e-08 | 251 | 171 | 11 | 27507650 | |
| Pubmed | MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 6.97e-08 | 9 | 171 | 4 | 16888623 | |
| Pubmed | 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). | 6.97e-08 | 9 | 171 | 4 | 12438239 | |
| Pubmed | Identification and characterization of the interaction between tuberin and 14-3-3zeta. | 6.97e-08 | 9 | 171 | 4 | 12176984 | |
| Pubmed | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. | 6.97e-08 | 9 | 171 | 4 | 16511560 | |
| Pubmed | 6.97e-08 | 9 | 171 | 4 | 18458160 | ||
| Pubmed | 14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains. | 6.97e-08 | 9 | 171 | 4 | 34294877 | |
| Pubmed | 6.97e-08 | 9 | 171 | 4 | 16581770 | ||
| Pubmed | 6.97e-08 | 9 | 171 | 4 | 12446771 | ||
| Pubmed | Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor. | 1.16e-07 | 10 | 171 | 4 | 14505491 | |
| Pubmed | 1.16e-07 | 10 | 171 | 4 | 20478393 | ||
| Pubmed | Involvement of protein kinase PKN1 in G2/M delay caused by arsenite. | 1.16e-07 | 10 | 171 | 4 | 15791647 | |
| Pubmed | 1.16e-07 | 10 | 171 | 4 | 12433946 | ||
| Pubmed | 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. | 1.16e-07 | 10 | 171 | 4 | 25154416 | |
| Pubmed | Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. | 1.16e-07 | 10 | 171 | 4 | 11697890 | |
| Pubmed | The structural basis for 14-3-3:phosphopeptide binding specificity. | 1.17e-07 | 3 | 171 | 3 | 9428519 | |
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 1.17e-07 | 3 | 171 | 3 | 12270931 | |
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 1.17e-07 | 3 | 171 | 3 | 2541251 | |
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 8617504 | ||
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 1.17e-07 | 3 | 171 | 3 | 2829183 | |
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 31991528 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | UBE4B PPP1R9A PPM1E GRIN1 GRM3 YWHAH YWHAZ PTK2 PPP3CA AP1B1 PLCL1 | 1.66e-07 | 281 | 171 | 11 | 28706196 |
| Pubmed | 1.81e-07 | 11 | 171 | 4 | 15696159 | ||
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 2.45e-07 | 53 | 171 | 6 | 23266187 | |
| Pubmed | 2.71e-07 | 12 | 171 | 4 | 39406751 | ||
| Pubmed | 2.71e-07 | 12 | 171 | 4 | 18779327 | ||
| Pubmed | BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma. | 2.71e-07 | 12 | 171 | 4 | 29686263 | |
| Pubmed | 2.71e-07 | 12 | 171 | 4 | 20642453 | ||
| Pubmed | Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. | 2.71e-07 | 12 | 171 | 4 | 19172738 | |
| Pubmed | 3.90e-07 | 13 | 171 | 4 | 22222486 | ||
| Pubmed | 3.90e-07 | 13 | 171 | 4 | 19014373 | ||
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 9705322 | ||
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 33396658 | ||
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 16968670 | ||
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 8515476 | ||
| Pubmed | 5.43e-07 | 14 | 171 | 4 | 15265780 | ||
| Pubmed | 5.43e-07 | 14 | 171 | 4 | 16093354 | ||
| Pubmed | 5.43e-07 | 14 | 171 | 4 | 12919677 | ||
| Pubmed | AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis. | 5.43e-07 | 14 | 171 | 4 | 36806887 | |
| Pubmed | SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. | 5.43e-07 | 14 | 171 | 4 | 33761321 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | SLC25A4 SLC25A5 SLC25A6 PKDREJ YWHAZ HNRNPF MET LRPPRC AP1B1 YWHAQ | 6.25e-07 | 256 | 171 | 10 | 24189400 |
| Pubmed | SLC25A5 SLC25A6 YWHAB YWHAH YWHAZ NUP205 LRPPRC PPP3CA YWHAQ | 6.31e-07 | 197 | 171 | 9 | 31620119 | |
| Pubmed | 7.38e-07 | 15 | 171 | 4 | 23572552 | ||
| Pubmed | Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. | 7.38e-07 | 15 | 171 | 4 | 16041367 | |
| Pubmed | 14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle. | 9.81e-07 | 16 | 171 | 4 | 23071090 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | SLC25A4 SLC25A5 SLC25A6 YWHAB YWHAZ HNRNPF LRPPRC PPP3CC YWHAQ | 1.07e-06 | 210 | 171 | 9 | 26217791 |
| Pubmed | TPTE EMC3 SLC25A5 PPP1R9A PPM1E SMPD4 YWHAB MTMR10 YWHAH YWHAZ PPP3CA PTPRB PPP3CC PDP1 PLCL2 KIRREL1 PEAK1 YWHAQ KNL1 | 1.13e-06 | 1049 | 171 | 19 | 27880917 | |
| Pubmed | Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. | 1.16e-06 | 5 | 171 | 3 | 19173300 | |
| Pubmed | The Cdk-like protein PCTAIRE-1 from mouse brain associates with p11 and 14-3-3 proteins. | 1.16e-06 | 5 | 171 | 3 | 9197417 | |
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 23938468 | ||
| Pubmed | Structural basis for protein-protein interactions in the 14-3-3 protein family. | 1.16e-06 | 5 | 171 | 3 | 17085597 | |
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 23383134 | ||
| Pubmed | A Cdc2-related protein kinase hPFTAIRE1 from human brain interacting with 14-3-3 proteins. | 1.16e-06 | 5 | 171 | 3 | 16775625 | |
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 11985497 | ||
| Pubmed | TRPM4 EMC3 SLC25A4 SLC25A5 SLC25A6 CYP51A1 SMPD4 DARS1 YWHAH YWHAZ CDKAL1 NUP205 TMX2 AP1B1 MRPS5 KIRREL1 SARAF TMEM41B | 1.21e-06 | 952 | 171 | 18 | 38569033 | |
| Pubmed | Interactome dynamics of RAF1-BRAF kinase monomers and dimers. | 1.28e-06 | 17 | 171 | 4 | 37045861 | |
| Pubmed | Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. | 1.64e-06 | 18 | 171 | 4 | 30240640 | |
| Pubmed | Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. | 2.06e-06 | 19 | 171 | 4 | 15142377 | |
| Pubmed | 2.06e-06 | 19 | 171 | 4 | 35343654 | ||
| Pubmed | 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. | 2.31e-06 | 6 | 171 | 3 | 11864996 | |
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 9369453 | ||
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 16672277 | ||
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 10620603 | ||
| Pubmed | Uncoupling proteins 2 and 3 interact with members of the 14.3.3 family. | 2.31e-06 | 6 | 171 | 3 | 10785390 | |
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 15163635 | ||
| Pubmed | C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. | 2.31e-06 | 6 | 171 | 3 | 9543386 | |
| Pubmed | Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. | 2.31e-06 | 6 | 171 | 3 | 10195903 | |
| Pubmed | PDS5B SLC25A4 SLC25A5 SLC25A6 PCDHGA3 MTRES1 SPEF2 PPP1R9A YWHAB LYST YWHAH YWHAZ HNRNPF TASOR2 NUP205 LRPPRC SNX25 SCG3 ASPM PHF14 CEP295 YWHAQ | 2.61e-06 | 1442 | 171 | 22 | 35575683 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 2.68e-06 | 175 | 171 | 8 | 25756610 | |
| Pubmed | Analysis of phosphorylation-dependent protein-protein interactions of histone h3. | 3.16e-06 | 21 | 171 | 4 | 25330109 | |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 21370995 | ||
| Pubmed | Identification of five novel 14-3-3 isoforms interacting with the GPIb-IX complex in platelets. | 4.03e-06 | 7 | 171 | 3 | 19558434 | |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 25639508 | ||
| Pubmed | Inhibitory interaction of the plasma membrane Na+/Ca2+ exchangers with the 14-3-3 proteins. | 4.03e-06 | 7 | 171 | 3 | 16679322 | |
| Pubmed | The cyclin-dependent kinase 11 interacts with 14-3-3 proteins. | 4.03e-06 | 7 | 171 | 3 | 15883043 | |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 15159416 | ||
| Interaction | GLCCI1 interactions | 2.30e-08 | 23 | 163 | 6 | int:GLCCI1 | |
| Interaction | FAM53B interactions | 2.56e-07 | 18 | 163 | 5 | int:FAM53B | |
| Interaction | KCNK15 interactions | 2.82e-07 | 8 | 163 | 4 | int:KCNK15 | |
| Interaction | FAM163A interactions | 3.45e-07 | 19 | 163 | 5 | int:FAM163A | |
| Interaction | KCNK9 interactions | 5.04e-07 | 9 | 163 | 4 | int:KCNK9 | |
| Interaction | RFX7 interactions | 5.96e-07 | 21 | 163 | 5 | int:RFX7 | |
| Interaction | CRTC2 interactions | 6.02e-07 | 61 | 163 | 7 | int:CRTC2 | |
| Interaction | PPP1R3D interactions | 7.67e-07 | 22 | 163 | 5 | int:PPP1R3D | |
| Interaction | OTOG interactions | 8.34e-07 | 10 | 163 | 4 | int:OTOG | |
| Interaction | PACS2 interactions | 1.22e-06 | 24 | 163 | 5 | int:PACS2 | |
| Interaction | ESRRB interactions | SLC25A5 SLC25A6 INTS1 MED14 WDR76 PKDREJ HNRNPF LRPPRC MTA1 PBRM1 YWHAQ ASCC3 | 1.55e-06 | 262 | 163 | 12 | int:ESRRB |
| Interaction | PARD3B interactions | 1.83e-06 | 46 | 163 | 6 | int:PARD3B | |
| Interaction | MAST4 interactions | 1.87e-06 | 26 | 163 | 5 | int:MAST4 | |
| Interaction | PPP1R3E interactions | 1.94e-06 | 12 | 163 | 4 | int:PPP1R3E | |
| Interaction | RASSF2 interactions | 2.08e-06 | 47 | 163 | 6 | int:RASSF2 | |
| Interaction | KCNK3 interactions | 2.79e-06 | 13 | 163 | 4 | int:KCNK3 | |
| Interaction | ARL3 interactions | 3.25e-06 | 78 | 163 | 7 | int:ARL3 | |
| Interaction | SPEG interactions | 3.30e-06 | 29 | 163 | 5 | int:SPEG | |
| Interaction | FAM117A interactions | 3.88e-06 | 14 | 163 | 4 | int:FAM117A | |
| Interaction | PABIR1 interactions | 4.67e-06 | 31 | 163 | 5 | int:PABIR1 | |
| Interaction | SCUBE1 interactions | 5.13e-06 | 5 | 163 | 3 | int:SCUBE1 | |
| Interaction | CEP112 interactions | 5.49e-06 | 32 | 163 | 5 | int:CEP112 | |
| Interaction | CCDC8 interactions | CACNA2D1 NIBAN1 EMC3 SLC25A6 PPP1R9A INTS1 DYRK1A DARS1 YWHAH YWHAZ HNRNPF NUP205 LRPPRC DNAH12 UBA6 RP2 YWHAQ ASCC3 | 6.39e-06 | 656 | 163 | 18 | int:CCDC8 |
| Interaction | SAMD4B interactions | 6.80e-06 | 122 | 163 | 8 | int:SAMD4B | |
| Interaction | SAMSN1 interactions | 6.96e-06 | 16 | 163 | 4 | int:SAMSN1 | |
| Interaction | MIS12 interactions | 7.86e-06 | 89 | 163 | 7 | int:MIS12 | |
| Interaction | FAM86C1P interactions | 8.68e-06 | 35 | 163 | 5 | int:FAM86C1P | |
| Interaction | ZNF395 interactions | 9.04e-06 | 17 | 163 | 4 | int:ZNF395 | |
| Interaction | SHROOM1 interactions | 1.16e-05 | 18 | 163 | 4 | int:SHROOM1 | |
| Interaction | PLEKHG5 interactions | 1.32e-05 | 38 | 163 | 5 | int:PLEKHG5 | |
| Interaction | TMCC3 interactions | 1.50e-05 | 39 | 163 | 5 | int:TMCC3 | |
| Interaction | FAM117B interactions | 1.70e-05 | 40 | 163 | 5 | int:FAM117B | |
| Interaction | PABIR2 interactions | 1.70e-05 | 40 | 163 | 5 | int:PABIR2 | |
| Interaction | PARP8 interactions | 1.81e-05 | 20 | 163 | 4 | int:PARP8 | |
| Interaction | MLXIP interactions | 1.81e-05 | 20 | 163 | 4 | int:MLXIP | |
| Interaction | MAPK7 interactions | 2.17e-05 | 143 | 163 | 8 | int:MAPK7 | |
| Interaction | MTMR10 interactions | 2.17e-05 | 42 | 163 | 5 | int:MTMR10 | |
| Interaction | SPATA13 interactions | 2.22e-05 | 21 | 163 | 4 | int:SPATA13 | |
| Interaction | SPIRE2 interactions | 2.22e-05 | 21 | 163 | 4 | int:SPIRE2 | |
| Interaction | STOX2 interactions | 2.22e-05 | 21 | 163 | 4 | int:STOX2 | |
| Interaction | DENND1B interactions | 2.22e-05 | 21 | 163 | 4 | int:DENND1B | |
| Interaction | CALM3 interactions | PPP1R9A INSRR WDR76 YWHAZ MET LRPPRC ADRB2 PPP3CA PPP3CC HECW2 ASPM PEAK1 | 2.38e-05 | 343 | 163 | 12 | int:CALM3 |
| Interaction | PPP4R4 interactions | 2.69e-05 | 22 | 163 | 4 | int:PPP4R4 | |
| Interaction | ATAT1 interactions | 2.69e-05 | 22 | 163 | 4 | int:ATAT1 | |
| Interaction | B3GNT8 interactions | 2.69e-05 | 22 | 163 | 4 | int:B3GNT8 | |
| Interaction | SAMD4A interactions | 2.74e-05 | 44 | 163 | 5 | int:SAMD4A | |
| Interaction | RGS12 interactions | 3.06e-05 | 45 | 163 | 5 | int:RGS12 | |
| Interaction | CCSER1 interactions | 3.24e-05 | 23 | 163 | 4 | int:CCSER1 | |
| Interaction | CIC interactions | SLC25A5 SLC25A6 INTS1 DYRK1A YWHAB TRIM22 YWHAH YWHAZ HNRNPF NUP205 ZBTB44 MTA1 PPP3CC ZFHX4 NOM1 PDS5A YWHAQ | 3.36e-05 | 673 | 163 | 17 | int:CIC |
| Interaction | CYP19A1 interactions | 3.41e-05 | 46 | 163 | 5 | int:CYP19A1 | |
| Interaction | E2F8 interactions | 3.86e-05 | 24 | 163 | 4 | int:E2F8 | |
| Interaction | ARL6IP6 interactions | 4.05e-05 | 78 | 163 | 6 | int:ARL6IP6 | |
| Interaction | KSR2 interactions | 4.21e-05 | 48 | 163 | 5 | int:KSR2 | |
| Interaction | CD80 interactions | 4.36e-05 | 79 | 163 | 6 | int:CD80 | |
| Interaction | SIK3 interactions | 4.36e-05 | 79 | 163 | 6 | int:SIK3 | |
| Interaction | LNP1 interactions | 4.57e-05 | 25 | 163 | 4 | int:LNP1 | |
| Interaction | C6orf132 interactions | 4.57e-05 | 25 | 163 | 4 | int:C6orf132 | |
| Interaction | TMCC1 interactions | 4.57e-05 | 25 | 163 | 4 | int:TMCC1 | |
| Interaction | TMEM102 interactions | 4.57e-05 | 25 | 163 | 4 | int:TMEM102 | |
| Interaction | NFATC3 interactions | 5.14e-05 | 50 | 163 | 5 | int:NFATC3 | |
| Interaction | CRY1 interactions | 5.30e-05 | 162 | 163 | 8 | int:CRY1 | |
| Interaction | FAM83G interactions | 5.37e-05 | 26 | 163 | 4 | int:FAM83G | |
| Interaction | PLEKHM3 interactions | 5.37e-05 | 26 | 163 | 4 | int:PLEKHM3 | |
| Interaction | AGAP2 interactions | 5.47e-05 | 210 | 163 | 9 | int:AGAP2 | |
| Interaction | CNKSR3 interactions | 5.66e-05 | 51 | 163 | 5 | int:CNKSR3 | |
| Interaction | USP43 interactions | 6.22e-05 | 52 | 163 | 5 | int:USP43 | |
| Interaction | CDK14 interactions | 6.22e-05 | 52 | 163 | 5 | int:CDK14 | |
| Interaction | SPIRE1 interactions | 6.26e-05 | 27 | 163 | 4 | int:SPIRE1 | |
| Interaction | TRIP12 interactions | 6.32e-05 | 214 | 163 | 9 | int:TRIP12 | |
| Interaction | LYST interactions | 6.83e-05 | 53 | 163 | 5 | int:LYST | |
| Interaction | FOXI2 interactions | 6.83e-05 | 53 | 163 | 5 | int:FOXI2 | |
| Interaction | CARMIL2 interactions | 7.26e-05 | 28 | 163 | 4 | int:CARMIL2 | |
| Interaction | SPATA18 interactions | 7.26e-05 | 28 | 163 | 4 | int:SPATA18 | |
| Interaction | KIAA0930 interactions | 7.26e-05 | 28 | 163 | 4 | int:KIAA0930 | |
| Interaction | USP31 interactions | 7.26e-05 | 28 | 163 | 4 | int:USP31 | |
| Interaction | WWC2 interactions | 7.26e-05 | 28 | 163 | 4 | int:WWC2 | |
| Interaction | DENND2B interactions | 7.26e-05 | 28 | 163 | 4 | int:DENND2B | |
| Interaction | BAD interactions | 7.50e-05 | 126 | 163 | 7 | int:BAD | |
| Interaction | TNS3 interactions | 7.51e-05 | 87 | 163 | 6 | int:TNS3 | |
| Interaction | ALKAL2 interactions | 8.17e-05 | 11 | 163 | 3 | int:ALKAL2 | |
| Interaction | CDCA7 interactions | 8.17e-05 | 11 | 163 | 3 | int:CDCA7 | |
| Interaction | FAM13A interactions | 8.37e-05 | 29 | 163 | 4 | int:FAM13A | |
| Interaction | PRKCE interactions | 8.42e-05 | 173 | 163 | 8 | int:PRKCE | |
| Interaction | NCAM2 interactions | 9.59e-05 | 30 | 163 | 4 | int:NCAM2 | |
| Interaction | ZFP36L1 interactions | 9.59e-05 | 30 | 163 | 4 | int:ZFP36L1 | |
| Interaction | ARAP2 interactions | 9.59e-05 | 30 | 163 | 4 | int:ARAP2 | |
| Interaction | TICRR interactions | 9.59e-05 | 30 | 163 | 4 | int:TICRR | |
| Interaction | ANKRD55 interactions | SLC25A5 SLC25A6 YWHAB YWHAH YWHAZ NUP205 LRPPRC PPP3CA YWHAQ | 1.03e-04 | 228 | 163 | 9 | int:ANKRD55 |
| Interaction | FRYL interactions | 1.06e-04 | 58 | 163 | 5 | int:FRYL | |
| Interaction | PLA2G5 interactions | 1.08e-04 | 12 | 163 | 3 | int:PLA2G5 | |
| Interaction | GNGT2 interactions | 1.08e-04 | 12 | 163 | 3 | int:GNGT2 | |
| Interaction | PDE7B interactions | 1.08e-04 | 12 | 163 | 3 | int:PDE7B | |
| Interaction | REM1 interactions | 1.08e-04 | 12 | 163 | 3 | int:REM1 | |
| Interaction | MACIR interactions | 1.09e-04 | 31 | 163 | 4 | int:MACIR | |
| Interaction | ALS2 interactions | 1.09e-04 | 31 | 163 | 4 | int:ALS2 | |
| Interaction | MAP3K9 interactions | 1.09e-04 | 31 | 163 | 4 | int:MAP3K9 | |
| Interaction | CRTC1 interactions | 1.09e-04 | 31 | 163 | 4 | int:CRTC1 | |
| Interaction | MS4A1 interactions | 1.15e-04 | 59 | 163 | 5 | int:MS4A1 | |
| Interaction | TRAPPC1 interactions | 1.15e-04 | 59 | 163 | 5 | int:TRAPPC1 | |
| Interaction | PLEKHA2 interactions | 1.16e-04 | 94 | 163 | 6 | int:PLEKHA2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 CASTOR2 SPDYE12 SPDYE11 SPDYE13 SPDYE15 SPDYE8 SPDYE14 | 9.50e-08 | 271 | 173 | 10 | chr7q11 |
| Cytoband | 7q11.23 | 3.49e-05 | 97 | 173 | 5 | 7q11.23 | |
| Cytoband | 4p16.3 | 3.11e-04 | 85 | 173 | 4 | 4p16.3 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 5.74e-08 | 7 | 117 | 4 | 1053 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 4.20e-05 | 11 | 117 | 3 | 1168 | |
| GeneFamily | Solute carriers | SLC25A4 SLC25A5 SLC25A6 SLC26A5 SLC25A26 SLC26A1 SLC25A32 SLC25A39 SLCO1A2 SLC22A2 SLC35E3 | 5.14e-05 | 395 | 117 | 11 | 752 |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.45e-03 | 9 | 117 | 2 | 1234 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | PDS5B CDK17 SEC16B CACNA2D1 NIBAN1 CYP51A1 SEMA5A PCDH17 TASOR2 TTLL7 ZBTB44 ADRB2 PTPRB ZFHX4 HECW2 UBA6 RP2 ASCC3 DSEL RAB27B | 5.66e-06 | 826 | 163 | 20 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.64e-08 | 193 | 169 | 9 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.65e-08 | 200 | 169 | 9 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.67e-07 | 193 | 169 | 8 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.98e-07 | 194 | 169 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.53e-07 | 46 | 169 | 5 | 37ea73d291e35b6865bd3ea4857275a6e5b299d1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.53e-07 | 46 | 169 | 5 | 69e9c8cbae3d15bd0823b8c6e48a9d2b9815296b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-07 | 197 | 169 | 8 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 199 | 169 | 8 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 170 | 169 | 7 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.16e-06 | 171 | 169 | 7 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 175 | 169 | 7 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-06 | 176 | 169 | 7 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-06 | 180 | 169 | 7 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.83e-06 | 180 | 169 | 7 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.27e-06 | 182 | 169 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-06 | 182 | 169 | 7 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-06 | 182 | 169 | 7 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.50e-06 | 183 | 169 | 7 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.97e-06 | 185 | 169 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 185 | 169 | 7 | 512a195ebbae445afe3722a3943020080daf2f3c | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.22e-06 | 186 | 169 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.75e-06 | 188 | 169 | 7 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-06 | 188 | 169 | 7 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-06 | 189 | 169 | 7 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.30e-06 | 190 | 169 | 7 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.30e-06 | 190 | 169 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.30e-06 | 190 | 169 | 7 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 190 | 169 | 7 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.89e-06 | 192 | 169 | 7 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.19e-06 | 193 | 169 | 7 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 9.19e-06 | 193 | 169 | 7 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.19e-06 | 193 | 169 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-06 | 193 | 169 | 7 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.19e-06 | 193 | 169 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.19e-06 | 193 | 169 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 9.51e-06 | 194 | 169 | 7 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 9.51e-06 | 194 | 169 | 7 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.51e-06 | 194 | 169 | 7 | 920955e775617d6156c5ee8b90d2cecd01a70e12 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.83e-06 | 195 | 169 | 7 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 169 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 196 | 169 | 7 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 196 | 169 | 7 | b1abecc0aafc09ca70a5fde624f2a998c4aa3341 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 198 | 169 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 198 | 169 | 7 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 198 | 169 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 198 | 169 | 7 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.09e-05 | 198 | 169 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 199 | 169 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-05 | 200 | 169 | 7 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-05 | 200 | 169 | 7 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-05 | 200 | 169 | 7 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-05 | 200 | 169 | 7 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 200 | 169 | 7 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.18e-05 | 148 | 169 | 6 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 152 | 169 | 6 | b61d2f6ee819c8dd4b4b601a8bc8388b1983de58 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-05 | 157 | 169 | 6 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-05 | 157 | 169 | 6 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-05 | 158 | 169 | 6 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-05 | 161 | 169 | 6 | 58381131e651744b5141b202f9d6063f55432db5 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-05 | 162 | 169 | 6 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-05 | 169 | 169 | 6 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 4.59e-05 | 169 | 169 | 6 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 4.59e-05 | 169 | 169 | 6 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 4.74e-05 | 170 | 169 | 6 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-05 | 170 | 169 | 6 | 3229f2a02bfa075aa61118552d0407fc018ab3d1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 173 | 169 | 6 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 173 | 169 | 6 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-05 | 174 | 169 | 6 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.39e-05 | 174 | 169 | 6 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.39e-05 | 174 | 169 | 6 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.39e-05 | 174 | 169 | 6 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-05 | 174 | 169 | 6 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-05 | 175 | 169 | 6 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-05 | 175 | 169 | 6 | 90302e8a44858ef3b2a165b88284d4788d591a99 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.57e-05 | 175 | 169 | 6 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 5.75e-05 | 176 | 169 | 6 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-05 | 176 | 169 | 6 | dc5a22f9d1347f157bdd93e6e5769b983deccf1a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.75e-05 | 176 | 169 | 6 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.93e-05 | 177 | 169 | 6 | f7a2e6b5e82f0565f8030696944f33c544233b94 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.93e-05 | 177 | 169 | 6 | ef02ee75db36a92dda889efb6fad1193efbc4be4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 177 | 169 | 6 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 177 | 169 | 6 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-05 | 178 | 169 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.12e-05 | 178 | 169 | 6 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.31e-05 | 179 | 169 | 6 | 06f92c884189197c86793191c05f65e34925c097 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.31e-05 | 179 | 169 | 6 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.51e-05 | 180 | 169 | 6 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.51e-05 | 180 | 169 | 6 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.71e-05 | 181 | 169 | 6 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.71e-05 | 181 | 169 | 6 | 2c660fcf0404c155955b67ab2958d6e6b0e30024 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 182 | 169 | 6 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 182 | 169 | 6 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 182 | 169 | 6 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 183 | 169 | 6 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 183 | 169 | 6 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| Drug | Clodronate | 3.81e-07 | 3 | 166 | 3 | DB00720 | |
| Drug | dehydroabietylamine | 1.51e-06 | 4 | 166 | 3 | ctd:C000600819 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 6.72e-07 | 4 | 164 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | FOXJ2 PDS5B ZBTB16 ATR PIEZO1 DYRK1A CASTOR2 IDUA SPDYE12 CDKAL1 NUP205 SCG3 PLCL2 SLC35E3 | 1.59e-04 | 799 | 164 | 14 | EFO_0010701 |
| Disease | HIV-1 infection | 2.23e-04 | 98 | 164 | 5 | EFO_0000180 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 4.07e-04 | 398 | 164 | 9 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | insulin-like growth factor-binding protein 7 measurement | 4.54e-04 | 6 | 164 | 2 | EFO_0008161 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 5.54e-04 | 29 | 164 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 8.23e-04 | 75 | 164 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | sarcoma (is_implicated_in) | 8.41e-04 | 8 | 164 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | cognitive function measurement, self reported educational attainment | 8.72e-04 | 355 | 164 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 9.68e-04 | 35 | 164 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | waist-hip ratio, metabolic syndrome | 1.08e-03 | 9 | 164 | 2 | EFO_0000195, EFO_0004343 | |
| Disease | acute kidney failure (is_implicated_in) | 1.34e-03 | 10 | 164 | 2 | DOID:3021 (is_implicated_in) | |
| Disease | Bipolar Disorder | 1.46e-03 | 477 | 164 | 9 | C0005586 | |
| Disease | triacylglycerol 56:2 measurement | 1.63e-03 | 11 | 164 | 2 | EFO_0010429 | |
| Disease | hearing impairment | 2.21e-03 | 98 | 164 | 4 | C1384666 | |
| Disease | basophil percentage of leukocytes | 2.45e-03 | 243 | 164 | 6 | EFO_0007992 | |
| Disease | Psychotic Disorders | 2.47e-03 | 101 | 164 | 4 | C0033975 | |
| Disease | Body Weight | 3.07e-03 | 15 | 164 | 2 | C0005910 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 3.07e-03 | 15 | 164 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Autosomal recessive primary microcephaly | 3.07e-03 | 15 | 164 | 2 | cv:C3711387 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 3.50e-03 | 16 | 164 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 3.50e-03 | 16 | 164 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 3.65e-03 | 352 | 164 | 7 | EFO_0007015 | |
| Disease | Benign neoplasm of stomach | 3.95e-03 | 17 | 164 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.95e-03 | 17 | 164 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 3.95e-03 | 17 | 164 | 2 | C0154060 | |
| Disease | alpha-L-iduronidase measurement | 3.95e-03 | 17 | 164 | 2 | EFO_0020139 | |
| Disease | intelligence, self reported educational attainment | 4.19e-03 | 117 | 164 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | prostate carcinoma | CACNA2D1 CDKAL1 TASOR2 DNAH12 SCUBE2 INSL6 AFM SLC22A2 COMMD7 PLCL1 CPNE4 KNL1 | 4.26e-03 | 891 | 164 | 12 | EFO_0001663 |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 4.36e-03 | 59 | 164 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | acute pancreatitis | 4.43e-03 | 18 | 164 | 2 | EFO_1000652 | |
| Disease | neutrophil count | FOXJ2 ZBTB16 DYRK1A WDR27 DARS1 SLC25A26 CDKAL1 MET STAC2 ADRB2 SCUBE3 KIRREL1 PLCL1 CPNE4 MS4A6A RAB27B | 4.51e-03 | 1382 | 164 | 16 | EFO_0004833 |
| Disease | Hallux valgus | 4.57e-03 | 60 | 164 | 3 | HP_0001822 | |
| Disease | health study participation | 4.77e-03 | 195 | 164 | 5 | EFO_0010130 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 4.79e-03 | 61 | 164 | 3 | DOID:3021 (biomarker_via_orthology) | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.93e-03 | 19 | 164 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 20:5 measurement | 4.93e-03 | 19 | 164 | 2 | EFO_0010364 | |
| Disease | abnormal paneth cell measurement | 4.93e-03 | 19 | 164 | 2 | EFO_0007963 | |
| Disease | smoking status measurement | ZBTB16 DPP10 WDR27 PTK2 MET LRPPRC TULP4 HECW2 PLCL2 COMMD7 CEP295 PLCL1 CPNE4 ASCC3 | 5.45e-03 | 1160 | 164 | 14 | EFO_0006527 |
| Disease | alpha-tocopherol measurement | 5.46e-03 | 20 | 164 | 2 | EFO_0007898 | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.48e-03 | 64 | 164 | 3 | DOID:4947 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSVFYYEILNSPEKA | 176 | P31946 | |
| ALNFSVFYYEILNNP | 171 | P27348 | |
| YFPTQALNFAFKDKY | 81 | P12236 | |
| RYFAITSPFKYQSLL | 131 | P07550 | |
| NPLLYAFLDGTFSKY | 296 | O00421 | |
| YVTFEPLKNSYQAFQ | 396 | Q63HQ2 | |
| FIEDPNFKNKVNYSY | 191 | Q9NY47 | |
| ALNFSVFYYEIQNAP | 176 | Q04917 | |
| QPTAENAYEYFTKIA | 101 | Q16611 | |
| AIPVTQYLKAFSSYQ | 206 | P43652 | |
| KTNGFILFLYFSDYS | 1141 | Q86UK0 | |
| YKDYLLKINFTAPFN | 431 | Q14832 | |
| AADIPAYYISTFKFD | 291 | A6NHX0 | |
| YFPTQALNFAFKDKY | 81 | P05141 | |
| KYQFNLYPETFALAS | 56 | Q14094 | |
| VKNNIDVFYFSTLYP | 816 | Q10567 | |
| NVIRTAKYNFYSFLP | 136 | O60423 | |
| TRIQPYYALQHSFFK | 466 | Q13627 | |
| VFSPKYNQKEFQLYS | 366 | Q96K78 | |
| TYNGSNLPAYFFKEL | 431 | Q96PN6 | |
| SRSHLPAVFYNQYFK | 66 | Q2M2E5 | |
| LSAKFADIYPLSNYD | 301 | P78312 | |
| FENNIYYQPDIKSSS | 196 | Q8N608 | |
| YYSFIKQNNPKFSAV | 461 | Q8IZT6 | |
| KDIRNYFQVSPEYFS | 851 | Q76M96 | |
| LYRYTDNKFNPKFIT | 26 | O00194 | |
| PNKLFFISVNDANYY | 376 | P20742 | |
| KSPQFNRYFYLLENI | 121 | Q9NTI5 | |
| PFKLEENYDNFYTVV | 411 | O14917 | |
| KSPQFNRYFYLLENL | 131 | Q29RF7 | |
| FSDNDKLYLYLQLPS | 56 | P48382 | |
| LFSQLQYLPFSNKEY | 1091 | Q92621 | |
| QYDPLYSKRFAVFLS | 381 | Q8IWT6 | |
| AALSKIFAVAATYPY | 231 | Q9H2D1 | |
| KFLSDQYNSQPAKYV | 716 | Q6NSI4 | |
| QYLLDAFFTRPFYKA | 1321 | Q9P2P5 | |
| AQFFLDTYTFTYPNI | 126 | Q6IE37 | |
| NLKAFLQQPDDYESY | 181 | O94952 | |
| FDFYELILYNPNGTK | 1201 | P23467 | |
| FQLLFNNAKSYYKPD | 116 | Q86U86 | |
| YILNTFYPKFNDKLA | 431 | P18428 | |
| SSVLSKLKFYYNPNF | 166 | Q96LI6 | |
| ASRNAYYFFVQEKIP | 6 | Q96JY0 | |
| KLRFFKSDYTYNPQF | 251 | Q8NCT3 | |
| YITYNAPAAISFLQK | 1966 | Q8N201 | |
| YSQPTDLQLLFAFEY | 166 | Q9NXD2 | |
| PVYEQQKSVFSKYFE | 301 | O95786 | |
| SIYPSTYSKQAAFQN | 156 | O00443 | |
| NPNAYDNLAIYKSFL | 631 | Q9H792 | |
| FVPLDYFYQLSSANT | 11 | A0A1B0GTH6 | |
| EFPNDQVKKYFVTSY | 116 | Q9H4M3 | |
| NDTILDVFFYNSPTY | 301 | O94830 | |
| EKDQYFPFYINLSAR | 1911 | Q6ZR08 | |
| AKFEITLFLSAYYPS | 2276 | Q8NG31 | |
| VYLQNEYKFSPTDFL | 171 | P42704 | |
| LYDLFFAFLQTGNYK | 891 | P42704 | |
| ISSNEEFKNYNFPKY | 416 | Q00537 | |
| PLYNTNHDFKFSYSE | 231 | Q9P0K8 | |
| YPDQDKFISVFYGAL | 266 | Q8NG92 | |
| PNDYFSKEASKLYFN | 196 | Q9P0J1 | |
| KQPALTADFVNYYFE | 611 | O94880 | |
| LNLALNPFEYYIFFF | 186 | Q9NXE4 | |
| YSLFDNSKLVEGFYP | 941 | O60244 | |
| FRFNPKFYSFLSAQE | 681 | Q8WY54 | |
| KEFPYFNYIQSKAFD | 276 | A2PYH4 | |
| SLQNYKLSPNDYFSL | 166 | Q9Y5H0 | |
| RNPVFQLESSFIYYK | 141 | Q9H3Q3 | |
| QYFLKFVPAGYESAL | 351 | Q13535 | |
| YQSFQVSEYVLPKFE | 216 | Q6YHK3 | |
| SFPSYSAYRIQKNAF | 2546 | Q99715 | |
| RSLDNDNYVFTAPYF | 766 | P54289 | |
| FLTAFLQNYQLAYSK | 36 | Q9Y6R7 | |
| VEEYKFPSLFINQFY | 381 | Q5VV42 | |
| EPYKFLQFAYFKANN | 146 | O75718 | |
| INPVYSKLFTVDFYF | 71 | Q96A23 | |
| LENAYEKYGPVFSFT | 91 | Q16850 | |
| ENVYIELTLPQFYSF | 171 | Q86VX2 | |
| FPKSKIYQAFYSEVF | 631 | Q5TEA3 | |
| SFFNPLIYTAFNKNY | 331 | P47898 | |
| YEKFNFRSNPNITFY | 1191 | Q5VV63 | |
| FPYALLSNDNAFLSY | 341 | P35475 | |
| QQAYSDSPQSLSKFY | 861 | Q99698 | |
| LKQPMFYSFLSSYAA | 3786 | Q99698 | |
| LDKNNIPTRSYVSYF | 151 | Q9H2W1 | |
| SFIVYYKESPFQNAT | 516 | P14616 | |
| QLSYENYEKFNSHPF | 681 | Q96J84 | |
| QSFLTRKYYFNNPED | 71 | Q9P0I2 | |
| LEAFSPVYKYAQDFL | 86 | P19447 | |
| QYVADNFPFYNKSKA | 151 | Q12951 | |
| QKRDTPLQFAFYKYS | 226 | Q6BAA4 | |
| FYSLPSKVRDLYAQF | 316 | Q8TDG4 | |
| APYSLTTQNEKYFEN | 2336 | Q9C0D2 | |
| FPNAAAFFITYEYVK | 61 | Q70HW3 | |
| PRFSKNITATFQYLY | 86 | O95104 | |
| LFDVLAHPQNYFKYT | 946 | Q8IWY4 | |
| ALFDVLAHPQNYFKY | 956 | Q9NQ36 | |
| AFFEVLAHPQNYFKY | 951 | Q8IX30 | |
| QFTVSLPNFFFLLYY | 266 | O15244 | |
| QILFATSTNLFYLPY | 1156 | Q8IZU8 | |
| FSAPNYLDVYNNKAA | 306 | Q08209 | |
| SLAAPVFNYADSIYL | 256 | Q9UJA2 | |
| EQSPEKAFLFTYYGL | 281 | Q6ZUA9 | |
| LPYKATENDIYNFFS | 296 | P52597 | |
| PIKYVHAFESNNFIY | 246 | P08581 | |
| SQQYRPYSFFTKLTA | 81 | P82675 | |
| TIKKNTLNPYYNEAF | 296 | O00445 | |
| QDLISNYSDYKFPDI | 1781 | Q9C093 | |
| IYSDFALKNPFYSLE | 176 | Q9Y296 | |
| AFVVYKLFLSDGQYS | 186 | Q96BY9 | |
| YAPSYEDFIKLINSN | 176 | Q9H3E2 | |
| FKYFYLASQSGQPLA | 431 | Q5TEA6 | |
| KIFQINAPIYYANSD | 536 | P58743 | |
| AQASEKVEAYSPYQF | 66 | Q9Y581 | |
| YALYFFPEQQRFNST | 1881 | Q9NTG1 | |
| KPTLNFFYQQVKSDY | 141 | Q05397 | |
| DIINKYAFFASEYPL | 501 | Q9UPR0 | |
| YAKYADFSISPNAVS | 141 | P55083 | |
| APFELQEITFKNYYT | 41 | Q9BSH3 | |
| EAPKQNIFYFLYEET | 176 | P0DUX0 | |
| EAPKQNIFYFLYEET | 176 | P0DTA3 | |
| EAPKQNIFYFLYEET | 176 | P0DUD1 | |
| NLTTFNPSILEKYYN | 206 | O43173 | |
| RAPNYKTLFYNIFSL | 51 | Q9P0P8 | |
| LKNPFYDSSDNPYTR | 61 | O95096 | |
| KTYNPFYAFLASKFC | 701 | Q5C9Z4 | |
| YFKSFPNLAFIRLNY | 261 | P51888 | |
| TVSYFKNNAYLAQSP | 236 | P14868 | |
| SYIEDFAKFENSPLY | 181 | P46721 | |
| YPTKRNEFHFNIYSF | 236 | Q9BQ13 | |
| FFFYSLVYDPQQKTL | 146 | Q13330 | |
| LSPSYFLGKEIFYSQ | 201 | Q8N5J4 | |
| FYYNELQSTFFLPEL | 286 | Q13591 | |
| ALNFSVFYYEILNSP | 171 | P63104 | |
| SDILKNYNNFYRFLP | 191 | Q8TBZ0 | |
| YFPTQALNFAFKDKY | 81 | P12235 | |
| KAYEALYNFSHFNPV | 1316 | Q8N3C0 | |
| IFSAPNYLDVYNNKA | 301 | P48454 | |
| QSFAPIYADLSLKYN | 171 | Q9Y320 | |
| YPFEAYKNCFLNLAI | 916 | A0AVT1 | |
| AYILDFQYPFSAVQA | 1516 | Q9NRJ4 | |
| EYPEDFVNYNKKFLS | 626 | Q15111 | |
| FVNYNKKFLSRIYPS | 631 | Q15111 | |
| PLYDDVKVQFFYSNL | 471 | P56180 | |
| QFFPYAALEKFARQY | 1926 | Q86UP3 | |
| SPKTFQQILEYAYTA | 76 | Q05516 | |
| KYIDFTSDYARNNPN | 211 | Q14587 | |
| FDSYTRFLKSPLYQE | 816 | O14924 | |
| TEAAIKNFSPYYSRQ | 21 | Q9BZQ8 | |
| PATAIYFTAYDQLKA | 136 | Q9BZJ4 | |
| LQPIYSLYTSFFANL | 96 | Q9H2B4 | |
| EAPKQNIFYFLYEET | 176 | P0DUX1 | |
| EAPKQNIFYFLYEET | 176 | A0A494C0Z2 | |
| EAPKQNIFYFLYEET | 176 | P0DUD3 | |
| EAPKQNIFYFLYEET | 176 | P0DUD4 | |
| EAPKQNIFYFLYEET | 176 | P0DUD2 | |
| IPFSTFQFLYTYIAK | 156 | Q9HAT0 | |
| SYVALYKFLPQENND | 296 | Q6ZMT1 | |
| FLFFIVQYSPQALYE | 891 | O95155 | |
| NYFLSPEKLTAENRY | 766 | Q9P2H5 | |
| DYFTKPDYQLLTSVF | 266 | Q6IQ55 | |
| YYPELAFQFKDAGLS | 151 | O75695 | |
| LANYFQSSDFLVPDY | 516 | Q8NCP5 | |
| IKQFFYNLIHPEYSA | 2171 | Q9H5I5 | |
| NFLTKSYNYVNLFLF | 2321 | Q9H5I5 | |
| PLSNKEFFKNYYGTN | 546 | Q9HBX9 | |
| SAFIPKYLYNFFLKD | 571 | Q8TEA7 | |
| SFIPSFQVYKLLYAS | 621 | Q96JE7 | |
| TAKVYLAPFSLSNYQ | 46 | Q9H967 | |
| YLFSDYVNVFSPKSH | 251 | Q5JVG2 | |
| EAPKQNIFYFLYEET | 176 | A0A494C191 | |
| TEYAFSLDSKYTNNP | 751 | Q5VWN6 | |
| LIAVYTFQFQDFPAY | 641 | Q92508 | |
| PIQSAQFYYIDAFIL | 601 | A2RRH5 | |
| AYFATYIFLQTFAIP | 116 | Q5BJD5 | |
| SSLSNNPLFQYKYLA | 41 | Q96MT1 | |
| FAFDPSVNYSKVYSR | 386 | Q8IYM9 | |
| FEELQYFPNFYALLK | 271 | Q8WXD2 | |
| YFPNFYALLKSIDSE | 276 | Q8WXD2 | |
| VILNSYYDVKFNFLG | 141 | Q7Z769 | |
| VQFPLDYNYSAFFLV | 221 | Q8TD43 | |
| QFFLRTPTYNLKYNS | 856 | Q6ZT98 | |
| SAPIKVFNTYSNEDY | 461 | Q9ULJ8 | |
| NERAQYIEFSKPFKY | 521 | Q05586 |